doi: 10.3389/fnagi.2025.1601602 Received 28 March 2025 Accepted 03 July 2025 Published 24 July 2025 Volume 17 - 2025 Edited by Rita Machado De Olivera, New University of Lisbon, Portugal Reviewed by Venkateswarlu Kanamarlapudi, Swansea University Medical School, United Kingdom Joon W Shim, Marshall University, United States Updates Copyright 2025 Li, Huang, Wang, Huang, Shi, Luo and Huang
Resultaterne fra NEJM 2023 og TRIUMPH-4 tegner et billede af et stof der ikke bare er en trinvis forbedring, det er et kvantitativt anderledes behandlingsresultat
Keep tightly closed
Tirzepatide mimics two hormones (GLP-1 and GIP) involved in blood sugar and appetite regulation, while semaglutide focuses on one (GLP-1)
You should not change your dosing regimen or stop taking compounded tirzepatide as prescribed without discussing with your provider first